Stocks News

LAST PRICE
83.5000
TODAY'S CHANGE (%)
Trending Up1.1000 (1.3350%)

Bid / Lots
83.4000/ 8
Ask / Lots
83.6000/ 8
Open / Previous Close
82.0300 / 82.4000
Day Range
Low 81.7400
High 84.9700
52 Week Range
Low 40.0100
High 177.3700
Volume
482,603
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Levi & Korsinsky Investigates Possible Securities Fraud Violations by TransMedics Group, Inc. (TMDX), from 4 hours ago by Dow Jones
  4 hours ago by Dow Jones
  Companies Mentioned: TMDX
  
  NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of TransMedics Group, Inc. ("TransMedics Group, Inc.") (NASDAQ:TMDX) concerning possible violations of federal securities laws.
Nov 1, 2024
- TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm, from 5:46PM ET on Friday Nov 01, 2024 by PR Newswire
  5:46PM ET on Friday Nov 01, 2024 by PR Newswire
  Companies Mentioned: TMDX
  The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving TransMedics Group, Inc. (NASDAQ: TMDX) focused on whether the company and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.
- TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm, from 5:46PM ET on Friday Nov 01, 2024 by Dow Jones
  5:46PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: TMDX
  
  SAN DIEGO, Nov. 1, 2024 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving TransMedics Group, Inc. (NASDAQ: TMDX) focused on whether the company and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.
- TransMedics Group, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - TMDX, from 7:26AM ET on Friday Nov 01, 2024 by Dow Jones
  7:26AM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: TMDX
  
  NEW YORK, NY / ACCESSWIRE / November 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of TransMedics Group, Inc. ("TransMedics Group, Inc.") (NASDAQ:TMDX) concerning possible violations of federal securities laws.
Oct 31, 2024
- TransMedics Group, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - TMDX, from 7:30AM ET on Thursday Oct 31, 2024 by Dow Jones
  7:30AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: TMDX
  
  NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of TransMedics Group, Inc. ("TransMedics Group, Inc.") (NASDAQ:TMDX) concerning possible violations of federal securities laws.

Today
- The Schall Law Firm Encourages Investors With Losses To Join An Inquiry Into Pacific Biosciences of California Inc For Fraud, from 58 minutes ago by Dow Jones
  58 minutes ago by Dow Jones
  Companies Mentioned: PACB
Yesterday
- Pacific Biosciences of California, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm, from 11:01AM ET on Sunday Nov 03, 2024 by Dow Jones
  11:01AM ET on Sunday Nov 03, 2024 by Dow Jones
  Companies Mentioned: PACB
Nov 2, 2024
- The Schall Law Firm Encourages Investors To Join An Inquiry Into Pacific Biosciences of California Inc For Securities Fraud, from 11:02AM ET on Saturday Nov 02, 2024 by Dow Jones
  11:02AM ET on Saturday Nov 02, 2024 by Dow Jones
  Companies Mentioned: PACB
Nov 1, 2024
- IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm, from 9:00PM ET on Friday Nov 01, 2024 by Dow Jones
  9:00PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: IRTC
- LeMaitre to Participate at Upcoming Investor Conferences in November, from 4:47PM ET on Friday Nov 01, 2024 by Dow Jones
  4:47PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: LMAT
- DJ LeMaitre Vascular Price Target Raised to $93.00/Share From $90.00 by Oppenheimer, from 1:00PM ET on Friday Nov 01, 2024 by Dow Jones
  1:00PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: LMAT
- DJ LeMaitre Vascular Is Maintained at Outperform by Barrington Research, from 11:41AM ET on Friday Nov 01, 2024 by Dow Jones
  11:41AM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: LMAT
- DJ iRhythm Technologies Is Maintained at Outperform by Baird, from 7:38AM ET on Friday Nov 01, 2024 by Dow Jones
  7:38AM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: IRTC
Oct 31, 2024
- LeMaitre Vascular Q3 Earnings, Sales Increase; Q4 Guidance Set, from 5:59PM ET on Thursday Oct 31, 2024 by MT Newswires
  5:59PM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: LMAT
- -- GUIDANCE: (LMAT) LEMAITRE VASCULAR Forecasts Q4 Revenue $54.9M - $56.9M, from 4:10PM ET on Thursday Oct 31, 2024 by MT Newswires
  4:10PM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: LMAT

Transmedics Group Inc
NASDAQ:TMDXUnited States

Search Criteria

Today

Levi & Korsinsky Investigates Possible Securities Fraud Violations by TransMedics Group, Inc. (TMDX), from 4 hours ago by Dow Jones

Nov 1, 2024

TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm, from 5:46PM ET on Friday Nov 01, 2024 by PR Newswire

TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm, from 5:46PM ET on Friday Nov 01, 2024 by Dow Jones

TransMedics Group, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - TMDX, from 7:26AM ET on Friday Nov 01, 2024 by Dow Jones

Oct 31, 2024

TransMedics Group, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - TMDX, from 7:30AM ET on Thursday Oct 31, 2024 by Dow Jones

Peers Headlines

Today

The Schall Law Firm Encourages Investors With Losses To Join An Inquiry Into Pacific Biosciences of California Inc For Fraud, from 58 minutes ago by Dow Jones

Yesterday

Pacific Biosciences of California, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm, from 11:01AM ET on Sunday Nov 03, 2024 by Dow Jones

Nov 2, 2024

The Schall Law Firm Encourages Investors To Join An Inquiry Into Pacific Biosciences of California Inc For Securities Fraud, from 11:02AM ET on Saturday Nov 02, 2024 by Dow Jones

Nov 1, 2024

IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm, from 9:00PM ET on Friday Nov 01, 2024 by Dow Jones

LeMaitre to Participate at Upcoming Investor Conferences in November, from 4:47PM ET on Friday Nov 01, 2024 by Dow Jones

DJ LeMaitre Vascular Price Target Raised to $93.00/Share From $90.00 by Oppenheimer, from 1:00PM ET on Friday Nov 01, 2024 by Dow Jones

DJ LeMaitre Vascular Is Maintained at Outperform by Barrington Research, from 11:41AM ET on Friday Nov 01, 2024 by Dow Jones

DJ iRhythm Technologies Is Maintained at Outperform by Baird, from 7:38AM ET on Friday Nov 01, 2024 by Dow Jones

Oct 31, 2024

LeMaitre Vascular Q3 Earnings, Sales Increase; Q4 Guidance Set, from 5:59PM ET on Thursday Oct 31, 2024 by MT Newswires

-- GUIDANCE: (LMAT) LEMAITRE VASCULAR Forecasts Q4 Revenue $54.9M - $56.9M, from 4:10PM ET on Thursday Oct 31, 2024 by MT Newswires